AA
IEIH

AlphaMark Advisors’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History

AlphaMark Advisors’s Portfolio IEIH Stock Details IEIH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-300
Closed -$10K – 748
2022
Q2 		$10K Hold
300
– – ﹤0.01% 402
2022
Q1 		$10K Hold
300
– – ﹤0.01% 407
2021
Q4 		$11K Hold
300
– – ﹤0.01% 386
2021
Q3 		$11K Hold
300
– – ﹤0.01% 395
2021
Q2 		$10K Buy
+300
New +$10K ﹤0.01% 401

AlphaMark Advisors's IEIH Position: Q3 2022 in Review

AlphaMark Advisors sold out of iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Q3 2022, closing a stake of 300 shares — an estimated $10K sold.

AlphaMark Advisors first reported a position in IEIH in Q2 2021 and held it in 5 quarters. The position peaked at $11K in Q4 2021. 0 funds tracked by Wall St. Rank hold IEIH as of Q3 2022.

  • AlphaMark Advisors reported no remaining iShares Evolved U.S. Innovative Healthcare ETF position as of Q3 2022 after selling out during the quarter.
  • AlphaMark Advisors sold 300 iShares Evolved U.S. Innovative Healthcare ETF shares in Q3 2022, an estimated $10K.
  • AlphaMark Advisors first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q2 2021 and held it in 5 quarters.
  • AlphaMark Advisors's iShares Evolved U.S. Innovative Healthcare ETF position peaked at $11K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q3 2022.

Based on AlphaMark Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.